Biogen
Biogen Inc.
225 Binney Street
Cambridge, MA 02142
Phone: (781) 464-2000Website: https://www.biogen.com/Careers: www.biogen.com/careers.html
Latest news
- Biogen to Discontinue the Development and Commercialization of Aduhelm (aducanumab-avwa)
31 January 2024 - FDA Approves Tofidence (tocilizumab-bavi), a Biosimilar to Actemra
29 September 2023 - FDA Grants Accelerated Approval for Qalsody (tofersen) for the Treatment of Amyotrophic Lateral Sclerosis Associated with a Mutation in the SOD1 Gene
25 April 2023 - Biogen Provides Update on FDA Advisory Committee Meeting on Tofersen for SOD1-ALS
23 March 2023 - FDA Accepts Biogen Biologics License Application for BIIB800, A Biosimilar Candidate Referencing Actemra® (tocilizumab)
9 December 2022 - Biogen Announces FDA’s 3-Month Extension of Review Period for the New Drug Application for Tofersen
17 October 2022 - The New England Journal of Medicine Publishes Pivotal Tofersen Data that Show Benefits in Rare, Genetic Form of ALS
21 September 2022 - FDA Accepts Biogen’s New Drug Application and Grants Priority Review of Tofersen for a Rare, Genetic Form of ALS
26 July 2022 - Biogen Announces Topline Results from the Tofersen Phase 3 Study and its Open-Label Extension in SOD1-ALS
17 October 2021 - FDA Approves Updated Aduhelm Prescribing Information to Emphasize Population Studied in Clinical Trials
8 July 2021
Drugs Associated with Biogen Inc.
Biogen Inc. manufactures, markets and/or distributes more than 15 drugs in the United States. Medications listed here may also be marketed under different names in different countries. Non-US country and region specific information is not available on this page.
| Brand/Generic Name | Reviews | Rating |
|---|---|---|
|
Avonex
Generic name: interferon beta-1a Drug class: interferons |
41 reviews | 7.2 / 10 |
|
Byooviz
Generic name: ranibizumab Drug class: anti-angiogenic ophthalmic agents |
||
|
Gazyva
Generic name: obinutuzumab Drug class: CD20 monoclonal antibodies |
3 reviews | 9.7 / 10 |
|
Leqembi
Generic name: lecanemab Drug class: miscellaneous central nervous system agents |
||
|
Ocrevus
Generic name: ocrelizumab Drug class: CD20 monoclonal antibodies |
164 reviews | 5.2 / 10 |
|
Plegridy
Generic name: peginterferon beta-1a Drug class: interferons |
11 reviews | 5.4 / 10 |
|
Qalsody
Generic name: tofersen Drug class: miscellaneous central nervous system agents |
||
|
Rituxan
Generic name: rituximab Drug class: antirheumatics, CD20 monoclonal antibodies |
49 reviews | 8.2 / 10 |
|
Skyclarys
Generic name: omaveloxolone Drug class: miscellaneous central nervous system agents |
2 reviews | 10 / 10 |
|
Spinraza
Generic name: nusinersen Drug class: miscellaneous uncategorized agents |
||
|
Tecfidera
Generic name: dimethyl fumarate Drug class: selective immunosuppressants |
92 reviews | 6.3 / 10 |
|
Tofidence
Generic name: tocilizumab Drug class: interleukin inhibitors |
||
|
Tysabri
Generic name: natalizumab Drug class: selective immunosuppressants |
92 reviews | 7.8 / 10 |
|
Vumerity
Generic name: diroximel fumarate Drug class: selective immunosuppressants |
6 reviews | 9.5 / 10 |
|
Zurzuvae
Generic name: zuranolone Drug class: miscellaneous antidepressants |
||
| For ratings, users were asked how effective they found the medicine while considering positive/adverse effects and ease of use (1 = not effective, 10 = most effective). | ||
Discontinued Drugs
| Brand/Generic Name | Reviews | Rating |
|---|---|---|
|
Aduhelm
Generic name: aducanumab Drug class: miscellaneous central nervous system agents |
||
| For ratings, users were asked how effective they found the medicine while considering positive/adverse effects and ease of use (1 = not effective, 10 = most effective). | ||